Ziska Pharmaceuticals Ltd.
Crizotinib Cancer (oncology)
Originator: Xalkori · Pfizer
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Crizona | 250 mg capsule | — | — | — | — |
| Crizona | 250 mg | Capsule | BDT 750 | US$6.10 | 3 x 10: ৳ 22,500.00 |
Empagliflozin Diabetes & metabolic
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Ajardy | 10 mg | Tablet | BDT 25 | US$0.20 | 3 x 10: ৳ 750.00 |
| Ajardy | 25 mg | Tablet | BDT 40 | US$0.33 | 1 x 10: ৳ 400.00 |
Linagliptin Diabetes & metabolic
Originator: Tradjenta · Boehringer Ingelheim (marketed in the US by Boehringer Ingelheim Pharmaceuticals, Inc.; co-promoted with Eli Lilly in several markets)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Linera | 5 mg | Tablet | BDT 18 | US$0.15 | 3 x 10: ৳ 540.00 |
Niraparib Cancer (oncology)
Originator: Zejula · GlaxoSmithKline (GSK); originally developed by Tesaro (Tesaro UK Limited)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Paribac | 100 mg capsule | — | — | — | — |
| Paribac | 100 mg | Capsule | BDT 850 | US$6.92 | 1 x 30: ৳ 25,500.00 |
Olaparib Cancer (oncology)
Originator: Lynparza · AstraZeneca (distributed by AstraZeneca Pharmaceuticals LP); developed and commercialised in collaboration with Merck (MSD outside the US and Canada)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Olakin | 150 mg | Tablet | BDT 700 | US$5.70 | 1 x 30: ৳ 21,000.00 |
Osimertinib Cancer (oncology)
Originator: Tagrisso · AstraZeneca
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Osikin | 80 mg tablet | — | — | — | — |
| Osikin | 80 mg | Tablet | BDT 425 | US$3.46 | 1 x 10: ৳ 4,250.00 |
Palbociclib Cancer (oncology)
Originator: Ibrance · Pfizer Inc. (Pfizer Laboratories Div Pfizer Inc)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Palbokin | 125 mg | Capsule | BDT 400 | US$3.26 | 3 x 7: ৳ 8,400.00 |
Tofacitinib Immunology & rheumatology
Originator: Xeljanz / Xeljanz XR · Pfizer (initial U.S. approval 2012)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Tofatin | 5 mg | Tablet | BDT 45 | US$0.37 | 1 x 10: ৳ 450.00 |
| Tofatin XR | 11 mg | Tablet (Extended Release) | BDT 80 | US$0.65 | 1 x 10: ৳ 800.00 |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.